Verity Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,040
| Closed | -$518K | – | 214 |
|
|
2025
Q1 | $518K | Buy |
1,040
+552
| +113% | +$275K | 0.21% | 109 |
|
|
2024
Q4 | $252K | Buy |
488
+30
| +7% | +$15.5K | 0.14% | 152 |
|
|
2024
Q3 | $283K | Buy |
+458
| New | +$283K | 0.11% | 164 |
|
|
2023
Q2 | – | Sell |
-820
| Closed | -$473K | – | 189 |
|
|
2023
Q1 | $473K | Buy |
820
+373
| +83% | +$215K | 0.28% | 95 |
|
|
2022
Q4 | $246K | Buy |
447
+20
| +5% | +$11K | 0.21% | 138 |
|
|
2022
Q3 | $217K | Buy |
+427
| New | +$217K | 0.22% | 153 |
|
|
2021
Q4 | – | Sell |
-422
| Closed | -$241K | – | 216 |
|
|
2021
Q3 | $241K | Buy |
+422
| New | +$241K | 0.16% | 158 |
|